Search for Clinical Trial Results
Angioedema - 87 Studies Found
Status | Study |
Completed |
Study Name: Efficacy, Safety and Tolerability of Icatibant for the Treatment of HAE Condition: Hereditary Angioedema Date: 2011-10-13 Interventions: Drug: Icatibant 30 mg subcutaneous dose of Icatibant |
Completed |
Study Name: Safety and Efficacy of Oral BCX4161 as a Prophylactic Treatment for HAE Condition: Hereditary Angioedema Date: 2013-11-05 Interventions:
|
Completed |
Study Name: EASSI - Evaluation of the Safety of Self-Administration With Icatibant Condition: Hereditary Angioedema Date: 2009-10-16 Interventions: Drug: Icatibant Single subcutaneous injection of icatibant, 30 mg |
Completed |
Study Name: A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of Subcutaneous CINRYZE Administration Condition: Hereditary Angioedema Date: 2010-02-22 Interventions: Biological: CINRYZE C1 esterase inhibitor (human) |
Completed |
Study Name: A Study to Evaluate the Safety and Pharmacology of Subcutaneous Administration of CINRYZE With Recombinant Human Hyaluronidase Condition: Hereditary Angioedema Date: 2011-08-25 Interventions: Biological: CINRYZE with rHuPH20 Other Names:
|
Completed |
Study Name: The Role of Vitamin D in Chronic Urticaria and Angioedema Treatment Condition:
|
Recruiting |
Study Name: Determination of Specific Biomarkers of Angioneurotic Crisis Condition: Angioedema Date: 2016-06-28 |
Completed |
Study Name: 12-Week Safety and Efficacy Study of BCX4161 as an Oral Prophylaxis Against HAE Attacks Condition:
Date: 2014-11-24 Interventions:
|
Recruiting |
Study Name: Determination of Specific Biomarkers of Acute Attack of Angioedema Within Pediatric Population Condition:
Date: 2016-07-18 Interventions: Other: blood sample |
Recruiting |
Study Name: Firazyr® Patient Registry Protocol (Icatibant Outcome Survey - IOS) Condition: Hereditary Angioedema (HAE) Date: 2009-12-17 |